Small nodule in rul having vats Nov22 2-13

Portal Forums Radiation Oncology Chest Radiation Small nodule in rul having vats Nov22 2-13

This topic contains 1 reply, has 2 voices, and was last updated by catdander forum moderator catdander forum moderator 4 years ago.

Viewing 2 posts - 1 through 2 (of 2 total)
Author Posts   
Author Posts
November 2, 2013 at 2:50 pm  #1260270    

merryc3

I have been told that if the nodule (2.2cm) is cancerous the standard would be to take the lobe out even if there is no lymph node involvement according to my PET. But I’ve recently read that there is a procedure that treats the area where the nodule is removed and the rest of the lobe treated with radioactive seeds . I believe they are sewn into a mesh bag and left in the lung rather than doing a lobectomy.
Is this a treatment being done in many hospitals ?

Thank you

Merry

November 2, 2013 at 3:49 pm  #1260272    
catdander forum moderator
catdander forum moderator

Hello Merry,

Surgery where only a section of the lobe is taken known as a wedge resection. Treatment given afterward known as adjuvant treatment is usually chemo sometimes with radiation added but normally they are reserved for masses 4cm or larger. Below are a couple of links on the subject.

http://cancergrace.org/lung/2013/10/27/options-for-elderly-with-early-stage-nsclc/

http://cancergrace.org/lung/2012/05/15/modifying-factors-adjuvant-chemo/ in this blog post Dr. West concludes, “The NCCN, recognizing that all of these factors, along with the size of the cancer, are associated with a higher risk of cancer recurrence in patients with stage I NSCLC after surgery, therefore offers a recommendation for consideration of chemotherapy in people with any or several of these higher risk features. I personally have generally followed a cut-off of 4 cm as the leading criterion for consideration of adjuvant chemotherapy, and fortunately I have the luxury of working with surgeons who do a great job on surgery and accurate staging. However, the more I review the evidence on other high risk features of the cancer, the more I recognize that if the goal is to identify people with a risk of recurrence that justifies the challenge of adjuvant chemotherapy, the more I step back and consider that these decisions, like so many others in cancer care, need to be individualized based on many factors, rather than based on a narrow set of rules”.

I hope this helps,
Janine

edit to add Dr. Weiss’ blog post, http://cancergrace.org/lung/2010/01/27/stereotactic-lung-radiotherapy-sbrt-vs-wedge-resection-for-stage-i-nsclc/

Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.